AMANDA FLOHR: Open Payments
NPI 1205491594 · PASADENA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,486 in 90 payments from 27 companies in 2025. Trend: 2023 $3,418 · 2024 $3,612 · 2025 $2,486
Food & beverage: $2,486
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 12 | $584 |
| Amgen Inc. | 15 | $292 |
| Novo Nordisk Inc | 12 | $267 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $201 |
| Corcept Therapeutics | 14 | $176 |
| Alexion Pharmaceuticals, Inc. | 2 | $155 |
| Insulet Corporation | 2 | $152 |
| Xeris Pharmaceuticals, Inc. | 4 | $112 |
| Radius Health, Inc. | 2 | $50 |
| Avvisto Therapeutics, LLC | 2 | $49 |
Products named: Dexcom G6 Transmitter, ISTURISA, Ozempic, Korlym, EVENITY, Omnipod, RECORLEV, TEPEZZA.
Industry payments across TX — which companies pay providers there.
